Home
About
Overview
Sharing Data
ORCID
Help
History (14)
Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.
Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy.
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.
Angiographic patency after robotic beating heart totally endoscopic coronary artery bypass grafting facilitated by automated distal anastomotic connectors.
Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis. J Stroke Cerebrovasc Dis. 2016 Nov; 25(11):2603-2609.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Brain Ischemia
Cerebral Hemorrhage
Chi-Square Distribution
Female
Fibrinolytic Agents
Humans
Infusions, Intravenous
Logistic Models
Louisiana
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Propensity Score
Registries
Retrospective Studies
Risk Factors
Stroke
Thrombolytic Therapy
Time Factors
Tissue Plasminogen Activator
Treatment Outcome
Wakefulness
Young Adult
authors with profiles
James Siegler